Overall (n = 660) | No mottling (n = 404) | Mottling (n = 256) | p | ||||
---|---|---|---|---|---|---|---|
Male gender | 469 | 71.1 | 275 | 68.1 | 194 | 75.8 | 0.020 |
Age (years), mean ± SD | 66.0 | ± 14.0 | 65.9 | ± 15.7 | 66.0 | ± 14.0 | 0.963 |
BMI (kg/m2), mean ± SD | 25.8 | ± 5.6 | 25.8 | ± 5.9 | 25.7 | ± 4.9 | 0.977 |
n | 644 | 394 | 250 | ||||
Risk factors, n (%) | |||||||
Current smoker | 182/634 | 28.7 | 107/387 | 27.7 | 75/247 | 30.4 | 0.461 |
Diabetes mellitus | 183/659 | 27.8 | 115/403 | 28.5 | 68/256 | 0.6 | 0.581 |
Arterial hypertension | 320 | 48.5 | 190 | 47.0 | 130 | 50.8 | 0.347 |
Dyslipidaemia | 236 | 35.8 | 137 | 33.9 | 99 | 38.7 | 0.214 |
Medical history, n (%) | |||||||
History of cardiac disease | 368 | 55.8 | 230 | 56.9 | 138 | 53.9 | 0.446 |
Ischaemic | 197 | 29.9 | 118 | 29.2 | 79 | 30.9 | 0.651 |
Hypertrophic | 10 | 1.5 | 7 | 1.7 | 3 | 1.2 | 0.748 |
Idiopathic | 65 | 9.9 | 47 | 11.6 | 18 | 7.0 | 0.053 |
Toxic | 26 | 3.9 | 12 | 3.0 | 14 | 5.5 | 0.108 |
Multisite pacing | 51 | 7.7 | 38 | 9.4 | 13 | 5.1 | 0.042 |
Defibrillator | 104 | 15.8 | 73 | 18.1 | 31 | 12.1 | 0.041 |
CABG | 54 | 8.2 | 36 | 8.9 | 18 | 7.0 | 0.391 |
PCI | 145 | 22.0 | 89 | 22.0 | 56 | 21.9 | 0.963 |
Peripheral artery disease | 80 | 12.1 | 41 | 10.2 | 39 | 15.2 | 0.051 |
Ischaemic stroke | 56 | 8.5 | 31 | 7.7 | 25 | 9.8 | 0.34.7 |
Chronic renal failure | 139 | 21.1 | 88 | 21.8 | 51 | 19.9 | 0.568 |
COPD | 45 | 6.8 | 28 | 6.9 | 17 | 6.6 | 0.885 |
Active neoplasy | 43 | 6.5 | 22 | 5.5 | 21 | 8.2 | 0.162 |
Previous medications, n (%) | |||||||
Aspirin | 250/659 | 37.9 | 157/404 | 38.9 | 93/255 | 36.5 | 0.538 |
P2Y12 inhibitor | 119/659 | 18.1 | 77/404 | 19.1 | 42/255 | 16.5 | 0.400 |
Statins | 243/659 | 36.9 | 154/404 | 38.1 | 89/255 | 34.9 | 0.404 |
Beta-blockers | 273/659 | 41.4 | 177/404 | 43.8 | 96/255 | 41.4 | 0.118 |
Vitamin K antagonist | 144/659 | 21.9 | 93/404 | 23.0 | 51/255 | 20.0 | 0.361 |
Direct oral anticoagulant | 50/659 | 7.6 | 29/404 | 7.2 | 21/255 | 8.2 | 0.618 |
ACE inhibitors or ARB | 248/659 | 37.6 | 154/404 | 38.1 | 94/255 | 36.9 | 0.746 |
Sacubitril/valsartan | 15/659 | 2.4 | 9/404 | 2.3 | 6/255 | 2.5 | 1.000 |
Furosemide | 325/659 | 49.3 | 210/404 | 52.0 | 115/255 | 45.1 | 0.085 |
Aldosterone antagonist | 94/659 | 14.3 | 67/404 | 16.6 | 27/255 | 10.6 | 0.032 |
Amiodarone | 119/643 | 18.5 | 66/391 | 16.9 | 53/252 | 21.0 | 0.186 |
Proton pump inhibitor | 236/650 | 36.3 | 152/397 | 38.3 | 84/253 | 33.2 | 0.189 |
Triggers | |||||||
Ischaemic | 255 | 38.6 | 151 | 37.4 | 104 | 40.6 | 0.404 |
Mechanical | 17 | 2.6 | 8 | 2.0 | 9 | 3.5 | 0.225 |
Ventricular arrhythmia | 83 | 12.6 | 45 | 11.1 | 38 | 14.8 | 0.162 |
Atrial arrhythmia | 95 | 14.4 | 56 | 13.9 | 39 | 15.2 | 0.624 |
Conductive disorders | 17 | 2.6 | 10 | 2.5 | 7 | 2.7 | 0.838 |
Infectious | 80 | 12.1 | 45 | 11.1 | 35 | 13.7 | 0.331 |
Non-compliance | 26 | 3.9 | 10 | 2.5 | 16 | 6.3 | 0.015 |
Iatrogenic | 49 | 7.4 | 29 | 7.2 | 20 | 7.8 | 0.762 |
Other | 88 | 13.3 | 57 | 14.1 | 31 | 12.1 | 0.462 |
None/undefined | 92 | 13.9 | 67 | 16.6 | 25 | 9.8 | 0.783 |